Summary & Overview
Postpartum and Post Abortion Diagnoses without O.R. Procedures: Inpatient Reimbursement Overview
DRG 776 encompasses postpartum and post abortion diagnoses without operating room procedures, covering nonoperative inpatient care after delivery or abortion. It matters for inpatient reimbursement because it groups similar clinical stays for prospective payment under Medicare, influencing payment levels based on documented diagnoses and resource use.
DRG 776 Overview
DRG 776 covers hospital inpatient cases for postpartum and post abortion diagnoses that do not involve operating room procedures. It captures admissions for routine and complication-related care after delivery or abortion when no surgical interventions are performed. This Diagnosis-Related Group is important for Medicare payment because it groups clinically similar stays to determine prospective reimbursement based on average resource use. Accurate coding and documentation of diagnoses and any complications affect payment assignment within the inpatient prospective payment structure.
Clinical Trials
- Acute management interventional studies assessing non-operative hemorrhage control strategies in postpartum patients: randomized or prospective cohort studies evaluating timing, dosing, and protocols for uterotonic administration, tranexamic acid use, or minimally invasive procedures performed without return to the operating room in patients with postpartum hemorrhage or retained products. These trials focus on immediate inpatient care for women admitted under DRG 776 who experience bleeding after delivery or abortion but are managed conservatively, and they examine hemostasis efficacy, transfusion requirements, and short-term complications. Results inform hospital clinical pathways, utilization of inpatient resources, and payer decisions around coverage for blood products and acute-care interventions.
- Comparative effectiveness and care-delivery studies of postpartum infection prevention and treatment strategies: pragmatic trials or observational comparative studies comparing antibiotic regimens, timing of therapy initiation, or bundled care pathways for endometritis, wound infections, or sepsis in postpartum and post-abortion populations. The patient population includes hospitalized postpartum or post-abortion patients with suspected or confirmed infection who are treated medically without operative procedures; outcomes include length of stay, readmission rates, antibiotic exposure, and antimicrobial stewardship metrics. These studies are relevant to clinicians optimizing inpatient treatment protocols and to payers concerned with reducing length of stay, antibiotic costs, and downstream readmissions.
- Post-discharge outcomes and health-services research evaluating maternal recovery trajectories and resource use after non-operative postpartum hospitalization: prospective cohort studies or registry-based research that track functional recovery, mental health (including postpartum depression and anxiety), lactation outcomes, and healthcare utilization (ED visits, readmissions, outpatient visits) in the weeks to months following discharge. The focus is on patients admitted with postpartum or post-abortion diagnoses managed without surgery, aiming to identify risk factors for poor recovery, disparities in follow-up care, and the impact of inpatient care practices on long-term outcomes. Findings help providers develop discharge planning and outpatient follow-up models and allow payers to anticipate post-discharge service needs and cost drivers for this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.